Manchester Financial’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.45M | Sell |
4,007
-23
| -0.6% | -$7.87K | 0.26% | 47 |
|
|
2026
Q1 | $1.42M | Sell |
4,030
-24
| -0.6% | -$8.56K | 0.27% | 50 |
|
|
2025
Q4 | $1.33M | Buy |
4,054
+330
| +9% | +$105K | 0.25% | 54 |
|
|
2025
Q3 | $1.05M | Sell |
3,724
-6
| -0.2% | -$1.74K | 0.21% | 58 |
|
|
2025
Q2 | $1.04M | Buy |
3,730
+2
| +0.1% | +$567 | 0.22% | 51 |
|
|
2025
Q1 | $1.16M | Sell |
3,728
-12
| -0.3% | -$3.54K | 0.26% | 40 |
|
|
2024
Q4 | $975K | Buy |
3,740
+25
| +0.7% | +$7.42K | 0.21% | 43 |
|
|
2024
Q3 | $1.2M | Hold |
3,715
| – | – | 0.26% | 35 |
|
|
2024
Q2 | $1.16M | Buy |
3,715
+142
| +4% | +$41.7K | 0.29% | 37 |
|
|
2024
Q1 | $1.02M | Sell |
3,573
-25
| -0.7% | -$7.32K | 0.26% | 38 |
|
|
2023
Q4 | $1.04M | Buy |
3,598
+12
| +0.3% | +$3.27K | 0.29% | 39 |
|
|
2023
Q3 | $964K | Sell |
3,586
-20
| -0.6% | -$4.99K | 0.28% | 38 |
|
|
2023
Q2 | $801K | Sell |
3,606
-1,070
| -23% | -$248K | 0.23% | 41 |
|
|
2023
Q1 | $1.13M | Buy |
4,676
+18
| +0.4% | +$4.42K | 0.33% | 34 |
|
|
2022
Q4 | $1.22M | Buy |
4,658
+154
| +3% | +$41.3K | 0.33% | 34 |
|
|
2022
Q3 | $1.01M | Sell |
4,504
-188
| -4% | -$45.6K | 0.29% | 39 |
|
|
2022
Q2 | $1.14M | Hold |
4,692
| – | – | 0.44% | 36 |
|
|
2022
Q1 | $1.14M | Buy |
4,692
+21
| +0.4% | +$4.83K | 0.41% | 37 |
|
|
2021
Q4 | $1.05M | Sell |
4,671
-36
| -0.8% | -$7.6K | 0.37% | 40 |
|
|
2021
Q3 | $1M | Sell |
4,707
-3,884
| -45% | -$894K | 0.38% | 41 |
|
|
2021
Q2 | $2.09M | Sell |
8,591
-462
| -5% | -$114K | 0.83% | 29 |
|
|
2021
Q1 | $2.25M | Buy |
9,053
+23
| +0.3% | +$5.49K | 1.04% | 24 |
|
|
2020
Q4 | $2.08M | Sell |
9,030
-35
| -0.4% | -$8.07K | 1.29% | 22 |
|
|
2020
Q3 | $2.3M | Sell |
9,065
-99
| -1% | -$24.5K | 1.75% | 17 |
|
|
2020
Q2 | $2.16M | Hold |
9,164
| – | – | 1.75% | 14 |
|
|
2020
Q1 | $1.86M | Sell |
9,164
-82
| -0.9% | -$17.9K | 1.37% | 15 |
|
|
2019
Q4 | $2.23M | Sell |
9,246
-26
| -0.3% | -$5.73K | 0.87% | 20 |
|
|
2019
Q3 | $1.79M | Buy |
9,272
+3,870
| +72% | +$743K | 0.79% | 21 |
|
|
2019
Q2 | $995K | Buy |
5,402
+44
| +0.8% | +$7.88K | 0.45% | 27 |
|
|
2019
Q1 | $1.02M | Buy |
5,358
+875
| +20% | +$167K | 0.49% | 26 |
|
|
2018
Q4 | $873K | Buy |
+4,483
| New | +$875K | 0.47% | 27 |
|
Other funds holding AMGN
Manchester Financial's AMGN Position: Q2 2026 in Review
Manchester Financial reduced its Amgen (AMGN) stake by 0.57% in Q2 2026, selling an estimated $7.87K and leaving 4,007 shares worth $1.45M. The position accounts for 0.26% of the portfolio, ranked #47.
Manchester Financial first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.3M in Q3 2020. 3,154 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Manchester Financial held 4,007 shares of Amgen worth $1.45M as of Q2 2026.
- Manchester Financial sold 23 Amgen shares in Q2 2026, an estimated $7.87K.
- Amgen made up 0.26% of Manchester Financial's portfolio in Q2 2026, its #47 holding.
- Manchester Financial first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- Manchester Financial's Amgen position peaked at $2.3M in Q3 2020.
- 3,154 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Manchester Financial's 13F filing for Q2 2026, filed 17 Jul 2026.